Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Bliss GVS Pharma Ltd - 506197 - Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2019.

 Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Board Meeting of the Company was held today i.e. on Monday, November 11, 2019 at the registered office of the Company. The Board has considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2019. A copy of unaudited financial results along with the Limited Review Report of the Auditor of the Company are enclosed herewith as Annexure-I. The meeting of the Board of Directors commenced at 6.30 p.m. and concluded at 9.15 p.m. Kindly take the same on record.
11-11-2019
Bigul

BLISS GVS PHARMA LTD. - 506197 - Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2019.

 Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Board Meeting of the Company was held today i.e. on Monday, November 11, 2019 at the registered office of the Company. The Board has considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2019. A copy of unaudited financial results along with the Limited Review Report of the Auditor of the Company are enclosed herewith as Annexure-I. The meeting of the Board of Directors commenced at 6.30 p.m. and concluded at 9.15 p.m. Kindly take the same on record.
11-11-2019
Bigul

Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Please find enclosed herewith the copy of the newspaper advertisement of notice of Board Meeting of the Company will be held on Monday, November 11, 2019 at the registered office of the Company, inter-alia, to consider and approve the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2019 published in 'The Economic Times' an English Daily and 'Maharashtra Times' a Regional Daily, on November 05, 2019. Kindly take the same on record.
05-11-2019
Bigul

Bliss GVS Pharma Ltd - 506197 - Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2019

 BLISS GVS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2019 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, we wish to inform you that the Board Meeting of the Company will be held on Monday, November 11, 2019, inter alia, to consider and approve the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2019. Further, pursuant to SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018, the trading window for dealing in shares of the Company was closed for all the Designated Persons and their immediate relatives of the Company from October 1, 2019 and shall remain closed till 48 hours after the announcement of the Financial Results i.e. up to Wednesday, November 13, 2019. Kindly acknowledge and take on record the same.
02-11-2019
Bigul

BLISS GVS PHARMA LTD. - 506197 - Certificate Under Regulation 40(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended September 30, 2019

 Please find enclosed herewith the half yearly compliance certificate issued by Company Secretary in Practice as per Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended September 30, 2019. Kindly take the same on record.
24-10-2019
Bigul

Bliss GVS Pharma Ltd - 506197 - Clarification

 With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Bliss GVS Pharma Ltd has submitted to BSE a copy of Clarification is enclosed.
24-10-2019
Bigul

Bliss GVS Pharma Ltd - 506197 - Clarification sought from Bliss GVS Pharma Ltd

 The Exchange has sought clarification from Bliss GVS Pharma Ltd on 23rd October, 2019 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
23-10-2019
Bigul

Bliss GVS Pharma Ltd - 506197 - Certificate Under Regulation 7(3) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended September 30, 2019

 Please find enclosed herewith certificate under Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended September 30, 2019. Kindly take the same on record.
22-10-2019
Bigul

BLISS GVS PHARMA LTD. - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Registrar and Share Transfer Agent of Company M/s. Universal Capital Securities Private Limited has received request for issue of duplicate share certificates consequent to loss of share certificates from the following shareholder.
18-10-2019
Bigul

Bliss GVS Pharma Ltd - 506197 - Shareholding for the Period Ended September 30, 2019

 Bliss GVS Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click here
14-10-2019
Next Page
Close

Let's Open Free Demat Account